EARNEST Partners
MR

EARNEST Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

EARNEST Partners’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,560
Closed – – 400
2016
Q1 		$0 Sell
5,560
-4,424,174
-100% -$120M ﹤0.01% 402
2015
Q4 		$120M Sell
4,429,734
-189,048
-4% -$4.87M 1.23% 17
2015
Q3 		$101M Buy
4,618,782
+56,113
+1% +$1.43M 0.99% 23
2015
Q2 		$130M Buy
4,562,669
+65,111
+1% +$1.9M 1.14% 18
2015
Q1 		$123M Sell
4,497,558
-148,608
-3% -$4.09M 1.06% 22
2014
Q4 		$123M Buy
4,646,166
+152,468
+3% +$4.46M 1.01% 23
2014
Q3 		$136M Buy
4,493,698
+556,320
+14% +$17.2M 1.13% 16
2014
Q2 		$124M Buy
3,937,378
+47,422
+1% +$1.51M 0.99% 28
2014
Q1 		$126M Buy
3,889,956
+85,577
+2% +$3M 1.01% 29
2013
Q4 		$138M Buy
+3,804,379
New +$148M 1.11% 20

EARNEST Partners's MR Position: Q2 2016 in Review

EARNEST Partners sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2016, closing a stake of 5,560 shares.

EARNEST Partners first reported a position in MR in Q4 2013 and held it in 10 quarters. The position peaked at $138M in Q4 2013. 1 fund tracked by Wall St. Rank holds MR as of Q2 2016.

  • EARNEST Partners reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2016 after selling out during the quarter.
  • EARNEST Partners sold 5,560 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2016.
  • EARNEST Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 10 quarters.
  • EARNEST Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $138M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2016.

Based on EARNEST Partners's 13F filing for Q2 2016, filed 15 Aug 2016.